¿Qué hay de nuevo en el síndrome de ovario poliquístico? / Whats new in polycystic ovary syndrome
Rev. chil. endocrinol. diabetes
; 6(2): 69-75, abr. 2013. ilus
Artigo
em Espanhol
| LILACS
| ID: lil-726577
Biblioteca responsável:
CL1.1
ABSTRACT
Polycystic ovary syndrome is recognized as a risk factor for the development of type 2 diabetes and metabolic syndrome. The prevalence of the condition is 6 to 10 percent in different populations. Its etiology is not well known and there are genetic and epigenetic phenomena involved. Due to its association with insulin resistance, it has been incorporated as another component of Reaven plurimetabolic syndrome. Therefore polycystic ovary syndrome evolved from an ovarian disease to a multisystem disorder and it must be considered a public health problem.
Texto completo:
Disponível
Coleções:
Bases de dados internacionais
Base de dados:
LILACS
Assunto principal:
Síndrome do Ovário Policístico
Tipo de estudo:
Fatores de risco
Limite:
Feminino
/
Humanos
Idioma:
Espanhol
Revista:
Rev. chil. endocrinol. diabetes
Assunto da revista:
Endocrinologia
Ano de publicação:
2013
Tipo de documento:
Artigo
/
Documento de projeto
País de afiliação:
Chile
Instituição/País de afiliação:
Hospital San Juan de Dios/CL
/
Universidad de Chile/CL